A new study published in The Permanente Journal and on the website for the National Library of Medicine has found that the cannabis compound cannabidiol (CBD) may be a potential treatment option for anxiety.
Researcher for the study note that a “recent surge in scientific publications has found preclinical and clinical evidence documenting value for CBD in some neuropsychiatric disorders, including epilepsy, anxiety, and schizophrenia, with evidence pointing toward “a calming effect for CBD in the central nervous system.” They note that “Interest in CBD as a treatment of a wide range of disorders has exploded, yet few clinical studies of CBD exist in the psychiatric literature.”
With that in mind, the objective of this study was to “determine whether CBD helps improve sleep and/or anxiety in a clinical population.”
Continue reading